Huawei Technologies Co., Limited

Shanghai Tianma Micro-Electronics Co., Ltd.

Tianma Micro-Electronics Co., Ltd.

Guangdong Oppo Mobile Telecommunications Corp., Ltd.

Semiconductor Manufacturing International (Shanghai) Corporation

Mellanox Technologies, Ltd.

Honor Device Co., Ltd.

Shanghai Bocimed Pharmaceutical Co., Ltd.

Hong Li

Yinghao Jin

Feng Han

Wei Tan

Peizhu Xie

Shengcheng Zhang

Shuai You

Hongxiang Fu

Jinfang Zhang

Wei Zhang

Jun Ma

Wenqi Sun

Weiwei Zhao

Hang Zhang

Jie Cui

Hao Kai Zhang

Anjian Li

Chenghui Peng

Tianyi Wu

Ying Liu

Conghua Ma

Tingting Wang

Wei Cheng

Cheng Cheng

Jing Han

Ke Xiao

Lin Wen

Shuhuan Ying

Xiaoqi Ding

Zhixiang Chen

A communication system () includes a plurality of Network Interface Controllers (NICs) () and one or more processors (). The plurality of NICs are to connect multiple hosts to a communication network, the NICs supporting a configurable Congestion Control (CC) scheme () selected from among multiple CC schemes. The one or more processors are coupled to the communication network, and are to receive performance indicators indicative of congestion states occurring in the communication network due to communication of the hosts with one another over the communication network, the performance indicators being associated with respective times of occurrence, select respective CC schemes for one or more of the NICs based on the performance indicators and corresponding times of occurrence, and provision the selected CC schemes in the one or more of the NICs.

Real-time performance optimization of a packet network

A fulvestrant pharmaceutical composition, a preparation method therefor, and an application thereof are provided. The fulvestrant pharmaceutical composition contains fulvestrant solid particles. The particle size of the fulvestrant solid particles satisfies that Dv(10) is selected from 0.400 micrometers to 6.000 micrometers, Dv(50) is selected from 0.700 micrometers to 6.000 micrometers, and Dv(90) is selected from 1.000 micrometers to 6.000 micrometers, provided that Dv(10) is not 0.400 micrometers, Dv(50) is not 0.700 micrometers, and Dv(90) is not 1.000 micrometers. The fulvestrant pharmaceutical composition has a long-acting sustained release.

Fulvestrant pharmaceutical composition, preparation method therefor, and application thereof

The present application discloses technologies handover methods, base stations, and terminal devices. One handover method includes: sending, by a source base station, a handover request to a target base station, where the handover request includes information about a first service of a terminal device, receiving, by the source base station, a handover response sent by the target base station, wherein the first service is supported by the target base station, the handover response includes information about a handover instruction for the first service, and the handover instruction is used to instruct the terminal device to hand over the first service from the source base station to the target base station, and sending, by the source base station, a handover response to the terminal device.eodcmaster.

Handover method, base station, and terminal device

LED panel light

Ceiling light

LED panel light set

Example communication methods and apparatus are described. One example method includes sending a handover request message to a target base station, where the handover request message is used to instruct to hand over a first session of a terminal device from the source base station to the target base station. The handover request message includes first information. The first information includes information about at least one quality of service (QoS) flow in the first session. The first session is a session corresponding to the terminal device. The source base station receives a handover request response message from the target base station, where the handover request response message includes second information. The second information is used to indicate that the target base station accepts a first QoS flow in the first session, and the at least one QoS flow includes the first QoS flow.

Communication method, base station, terminal device, and system

A communication method and a communications device are provided. In the method, a first base station receives a first message; the first base station determines, based on the first message, whether to allocate a new RNA to a terminal in an inactive state; and the first base station allocates a new RNA to the terminal in the inactive state after determining to allocate a new RNA to the terminal in the inactive state, so as to reduce signaling overheads; and/or the first base station receives a second message; the first base station determines a communication status of the terminal in the inactive state based on the second message; and after determining that the terminal needs to change the communication status, the first base station controls the terminal to change the communication status.

Communication method and communications device

Embodiments of the present invention propose a communication method. The communication method includes: obtaining, by a base station, DRB configuration information, where the DRB configuration information is used to determine a mapping relationship between serving cells and DRBs used to carry data of different service types; and sending the DRB configuration information to a terminal, so that the terminal communicates with the base station in a serving cell corresponding to a DRB. The embodiments of the present invention further disclose a base station and a terminal to which the communication method is applied.

Communication method, base station, and terminal

Embodiments provide a duplication transmission method and apparatus. The method includes: receiving, by a terminal device, duplication transmission configuration information sent by a radio access network RAN device, where the duplication transmission configuration information includes configurations of at least one of a duplication transmission mode or duplication transmission content of the terminal device; and performing, by the terminal device, duplication transmission based on the duplication transmission configuration information.

Duplication transmission method and apparatus

This application provides an RNA allocation method, a network device, and a terminal. The method includes receiving, by a first network device, a second message sent by a second network device, where the second message carries RPA information of the second network device, and the RPA information is used to identify an RPA. The method also includes sending, by the first network device, a third message to the second network device.

RNA allocation method, network device, and terminal

Growing community of inventors

Shanghai, China

Hong Li